1. Home
  2. NIM vs FHTX Comparison

NIM vs FHTX Comparison

Compare NIM & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Select Maturities Municipal Fund

NIM

Nuveen Select Maturities Municipal Fund

N/A

Current Price

$8.69

Market Cap

114.9M

Sector

Finance

ML Signal

N/A

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

N/A

Current Price

$1.79

Market Cap

111.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NIM
FHTX
Founded
1992
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.9M
111.1M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NIM
FHTX
Price
$8.69
$1.79
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $4.17
AVG Volume (30 Days)
33.3K
★ 685.0K
Earning Date
01-01-0001
11-09-2026
Dividend Yield
★ 3.46%
N/A
EPS Growth
N/A
★ 25.32
EPS
N/A
★ 0.43
Revenue
N/A
★ $30,909,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$4.14
Revenue Growth
N/A
★ 36.75
52 Week Low
$8.46
$1.73
52 Week High
$9.94
$7.61

Technical Indicators

Market Signals
Indicator
NIM
FHTX
Relative Strength Index (RSI) 39.08 33.87
Support Level $8.46 N/A
Resistance Level $9.45 $2.28
Average True Range (ATR) 0.15 0.17
MACD -0.06 0.03
Stochastic Oscillator 20.42 7.27

Price Performance

Historical Comparison
NIM
FHTX

About NIM Nuveen Select Maturities Municipal Fund

Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its primary investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital. Its secondary investment objective is to enhance portfolio value relative to the municipal bond market through investments in tax-exempt municipal obligations that are underrated or undervalued, or that represent municipal market sectors that are undervalued. The fund has single operating segment.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Share on Social Networks: